TWEAK-Akt association has been shown in other systems, such as the heart [72], skeletal muscles [73], and tumors [74,75], including glioma, where Akt2 was specifically implicated in mediating TWEAK-induced cell survival [76]. Here, TNFSF12 is linked to central nervous system cancer.